Physician profile
Lauren E Granger
NPI 1407176738
$855.50
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $74.85 · 2022: $335 · 2023: $336.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $336.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $289.05 | 2022-2023 | Azstarys |
| Tris Pharma INC | $161.83 | 2019-2023 | Dyanavel Xr |
| Ironshore Pharmaceuticals INC. | $130.13 | 2020-2023 | Jornay Pm |
| Pfizer INC. | $65.08 | 2019-2023 | |
| Cranial Technologies, INC | $63.37 | 2019-2023 | Doc Band |
| Merck Sharp & Dohme LLC | $42.97 | 2022-2023 | Gardasil 9, Vaxneuvance, Rotateq |
| Adlon Therapeutics L.P. | $35.12 | 2020 | |
| Sobi, INC | $19.78 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $18.20 | 2023 | Flumist Quadrivalent |
| Neos Therapeutics, LP | $15.87 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.10 | 2023 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Granger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.